OncoSec Medical Inc (ONCSQ)

[chickpea598]

Was it a whim that Oncosec took a subset of patients and administered the PD-1 after monotherapy treatment? I don't recall any information being released about taking patients from the long-term monotherapy trial and doing a teaser run before the combo trial data release. If they actually did screen this subset of patients with the Biomarker test and they were non-responders that would be stronger validation for the combo trial data to come out this fall. Even though it was not a requirement for the monotherapy trial I wonder if Oncosec did screen this subset of patients with the Biomarker test and didn't release that information. Just curious if there is some crucial missing information in all this.